Molecular pathogenesis of colorectal cancer

Hematology/Oncology Clinics of North America

Volumn 11, Issue 4, 1997, Pages 609-633

  Hoops, T C ^a   Traber, P G ^a  

^a 142 Clinical Research Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; GENE PRODUCT; HERMES ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P21; PROTEIN P53;

ADENOMATOUS POLYP; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER SCREENING; COLON ADENOMA; COLORECTAL CARCINOMA; DNA REPAIR; DRUG DEVELOPMENT; GENE DELETION; GENE FUNCTION; GENE MUTATION; HUMAN; ONCOGENE C MYC; ONCOGENE RAS; ONCOGENE SRC; PRIORITY JOURNAL; RECTUM ADENOMA; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030840695     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70453-6     Document Type: Article

References (124)

1. I. Albanese M. Alberti V. Bazan Structural analysis of c-myc in human sporadic colorectal carcinomas Anticancer Res 14 1994 1103 1106
2. A. Auvinen J. Isola T. Visakorpi Overexpression of p53 and long-term survival in colon carcinoma Br J Cancer 70 1994 293 296
3. 1 to S phase EMBO J 14 1995 56118 55625
4. A. Bellacosa M. Genuardi M. Anti Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects Am J Med Genet 62 1996 353 364
5. C. Béroud T. Soussi APC gene: Database of germline and somatic mutations in human tumors and cell lines Nucl Acids Res 24 1996 121 124
6. c-src protein kinase activity in human colon carcinoma Proc Natl Acad Sci USA 84 1987 2251 2255
7. S.K. Boolbol A.J. Dannenberg A. Chadburn Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis Cancer Res 56 1996 2556 2560
8. J.L. Bos p21ras: An oncoprotein functioning in growth factor-induced signal transduction Eur J Cancer 31A 1995 1051 1054
9. J.A. Brennan L. Mao R.H. Hruban Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck N Engl J Med 332 1995 429 435
10. C.E. Bronner S.M. Baker P.T. Morrison Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer Nature 368 1994 258 261
11. S.J. Browne A.C. Williams A. Hague Loss of APC protein expressed by human colonic epithelial cells and the appearance of a low-molecular-weight form is associated with apoptosis in vitro Int J Cancer 59 1994 56 64
12. C.A. Cartwright C.A. Coad B.M. Egbert Elevated c-Src tyrosine kinase activity in premalignant epithelia in ulcerative colitis J Clin Invest 93 1994 509 515
13. c-src activation in human colon carcinoma J Clin Invest 83 1989 2025 2033
14. c-src protein kinase is an early event in colonic carcinogenesis Proc Natl Acad Sci USA 87 1990 558 562
15. C.-M. Choung T.-X. Jiang E. Yin cDCC (chicken homologue to a gene deleted in colorectal carcinoma) is an epithelial adhesion molecule expressed in the basal cells and involved in epithelial-mesenchymal interaction Dev Biol 164 1994 383 397
16. P. Cowin Unraveling the cytoplasmic interactions of the cadherin superfamily Proc Natl Acad Sci USA 91 1994 10759 10761
17. L.J. Curtis V.J. Bubb S. Gledhill Loss of heterozygosity of MCC is not associated with mutation of the retained allele in sporadic colorectal cancer Hum Mol Genet 3 1994 443 446
18. L.A. Donehower M. Harvey B.L. Slagle Mice deficient for p53 are developmentally normal but suceptible to spontaneous tumours Nature 356 1992 215 221
19. J.T. Drummond G.-M. Li M.J. Longley Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells Science 268 1995 1909 1912
20. R.N. DuBois A. Radhika B.S. Reddy Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 110 1996 1259 1262
21. C.E. Eberhart R.J. Coffey A. Radhika Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
22. 1 arrest and apoptosis Cancer Res 54 1994 1169 1174
23. K. Eppert S.W. Scherer H. Ozcelik MAFR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma Cell 86 1996 543 552
24. M.D. Erisman J.K. Scott R.A. Watt The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines Oncogene 2 1988 367 378
25. E.R. Fearon K.R. Cho J.M. Nigro Identification of a chromosome 18q gene that is altered in colorectal cancers Science 247 1990 49 56
26. E.R. Fearon B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
27. S. Fields S.K. Jang Presence of a potent transcription activating sequence in the p53 protein Science 249 1990
28. C.A. Finlay P.W. Hinds T.-H. Tan Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life Mol Cell Biol 8 1988 531 539
29. R. Fishel M.K. Lescoe M.R.S. Rao The human mutator gene MSH2 and its association with hereditary nonpolyposis colon cancer Cell 75 1993 1027 1038
30. F.M. Giardiello S.R. Hamilton A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1993 1313 1316
31. J.B. Gibbs A. Oliff N.E. Kohl Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic Cell 77 1994 175 178
32. E. Giovannucci K.M. Egan D.J. Hunter Aspirin and the risk of colorectal cancer in women N Engl J Med 333 1995 609 614
33. T.M. Gottlieb M. Oren p53 in growth control and neoplasia Biochim Biophys Acta 128 1996 77 102
34. M.S. Greenblatt W.P. Bennett M. Hollstein Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis Cancer Res 54 1994 4855 4878
35. J. Groden A. Thliveris W. Samowiz Identification and characterization of the familial adenomatous polyposis coli gene Cell 66 1991 589 600
36. U. öunthert M. Hofmann W. Rudy A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell 65 1991 13 24
37. S.A. Hahn M. Schutte A.T.M. Hoque DPC4 , A candidate tumor suppressor gene at chromosome 18q21.1 Science 271 1996 350 353
38. R. Hamelin P. Laurent-Puig S. Olschwang Association of p53 mutations with short survival in colorectal cancer Gastroenterology 106 1994 42 48
39. S.R. Hamilton B. Liu R.E. Parsons The molecular basis of Turcot's syndrome N Engl J Med 332 1995 839 847
40. L. Hedrick K.R. Cho E.R. Fearon The DCC gene product in cellular differentiation and colorectal tumorigenesis Genes Dev 8 1994 1174 1183
41. K.-H. Heider M. Hofmann E. Hors A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps J Cell Biol 120 1993 227 233
42. L. Herrera S. Kakati L. Gibas Brief clinical report: Gardner syndrome in a man with an interstitial deletion of 5q Am J Med Genet 25 1986 473 476
43. M. Inomata A. Achiai S. Akimoto Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients Cancer Res 56 1996 2213 2217
44. F. Itoh Y. Hinoda M. Ohe Decreased expression of DCC mRNA in human colorectal cancers Int J Cancer 53 1993 260 263
45. J. Jen H. Kim S. Piantadosi Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 331 1994 213 221
46. S.L. Kargman G.P. O'Neill P.J. Vickers Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Res 1995 55
47. S.E. Kern K.W. Kinzler A. Bruskin Identification of p53 as a sequence-specific DNA-binding protein Science 252 1991 1708 1711
48. K.W. Kinzler M.C. Nilbert L. Su Identification of FAP locus genes from chromosome 5q21 Science 253 1991 661 665
49. K.W. Kinzler M.C. Nilbert B. Vogelstein Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers Science 251 1991 1366 1370
50. L.J. Ko C. Prives p53: Puzzle and paradigm Genes Dev 10 1996 1054 1072
51. R.D. Kolodner Mismatch repair: Mechanisms and relationship to cancer susceptibility T.I.B.S. 20 1995 397 401
52. P.A. Kolodziej L.C. Timpe K.J. Mitchell frazzled encodes a drosophila member of the DCC immunoglobulin subfamily 7 and is required for CNS and motor axon guidance Cell 87 1996 197 204
53. M. Konishi R. Kikuchi-Yanoshita K. Tanaka Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer Gastroenterology 111 1996 307 317
54. H. Land L.F. Parada R.A. Weinberg Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes Nature 304 1983 596 601
55. D.P. Lane L.V. Crawford T antigen is bound to a host protein in SV40-transformed cells Nature 278 1979 261 263
56. S.J. Lanspa J.X. Jenkins R.J. Cavalieri Surveillance in Lynch syndrome: How aggressive? Am J Gastroenterol 89 1994 1978 1980
57. F.S. Leach N.C. Nicolaides N. Papadopoulos Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer Cell 75 1993 1215 1225
58. M. Leppert M. Dobbs P. Scambler The gene for familial polyposis coli maps to the long arm of chromosome 5 Science 238 1987 1411 1413
59. A.J. Levine M.C. Wu A. Chang The spectrum of mutations at the p53 locus Ann NY Acad Sci 768 1995 111 128
60. D.I.H. Linzer A.J. Levine Characterization of a 54K dalton cellular tumor antigen present in SV40-transformed and uninfected embryonal carcinoma cells Cell 17 1979 43 52
61. L. Losi L. Roncucci C. Di Gregorio K-ras and p53 mutations in human colorectal aberrant crypt foci J Pathol 178 1996 259 263
62. H.T. Lynch T. Smyrk J. Lynch Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer Eur J Cancer 31A 1995 1039 1046
63. H.T. Lynch T. Smyrk J.F. Lynch Overview of natural history, molecular genetics and management of HNPCC (Lynch syndrome) Int J Cancer 69 1996 38 43
64. Min-induced intestinal neoplasia Cell 1481 1995 957 966
65. D. Malkin F.P. Li L.C. Strong Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238
66. S. Markowitz J. Wang L. Myeroff Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
67. G. Marra C.R. Boland Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives J Natl Cancer Inst 87 1995 1114 1125
68. E.A. McLellan R.P. Bird Aberrant crypts: Potential preneoplastic lesions in the murine colon Cancer Res 48 1988 6187 6192
69. M.F. Melhem A.I. Meisler G.G. Finley Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors Cancer Res 52 1992 5853 5864
70. J.R. Miller R.T. Moon Signal transduction through β-catenin and specification of cell fate during embryogenesis Genes Dev 10 1996 2527 2539
71. T. Miyashita J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
72. Y. Miyoshi H. Ando H. Nagase Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients Proc Natl Acad Sci USA 89 1992 4452 4456
73. Y. Miyoshi H. Nagase H. Ando Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene Hum Mol Genet 1 1992 229 233
74. A.R. Moser H.C. Pitot W.F. Dove A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 247 1990 322 324
75. S. Munemitsu I. Albert B. Souza Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein Proc Natl Acad Sci USA 92 1995 3046 3050
76. T. Muto H.J.R. Bussey B.C. Morson The evolution of cancer of the colon and rectum Cancer 36 1975 2251
77. N.C. Nicolaides N. Papadopoulos B. Liu Mutations of two PMS homologues in hereditary nonpolyposis colon cancer Nature 371 1994 75 80
78. I. Nishisho Y. Nakamura Y. Miyoshi Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients Science 253 1991 665 669
79. S. Olschwang A. Tiret P. Laurent-Piug Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients Cell 75 1993 959 968
80. Z.N. Oltvai C.L. Milliman S.J. Korsmeyerq Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609 619
81. K. Ookawa M. Sakamoto S. Hirohashi Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal cancers Int J Cancer 53 1993 382 387
82. 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
83. F. Palombo P. Gallinari I. Iaccarino GTBP, a 160 kilodalton protein essential for mismatch-binding activity in human cells Science 268 1995 1912 1914
84. N. Papadopoulos N.C. Nicolaides B. Liu Mutations of GTBP in genetically unstable cells Science 1995 268
85. J. Park C.A. Cartwright Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells Mol Cell Biol 15 1995 2374 2382
86. + tumor cells Cell 75 1993 1227 1236
87. N.P. Pavletich K.A. Chambers C.O. Pabo The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots Genes Dev 7 1993 256 264
88. W.E. Pierceall M.A. Reale A.F. Candia Expression of a homologue of the deleted colorectal cancer (DCC) gene in the nervous system of developing Xenopus embryos Dev Biol 166 1994 654 665
89. K. Polyak S.R. Hamilton B. Vogelstein Early alteration of cell-cycle–regulated gene expression in colorectal neoplasia Am J Pathol 149 1996 381 387
90. S.M. Powell N. Zilz Y. Beazer-Barclay APC mutations occur early during colorectal tumorigenesis Nature 359 1992 235 237
91. S. Presciuttini L. Varesco P. Sala Age of onset in familial adenomatous polyposis: Heterogeneity within families and among APC mutations Ann Hum Genet 58 1994 331 342
92. T.P. Pretlow B.J. Barrow W.S. Ashton Aberrant crypts: Putative preneoplastic foci in human colonic mucosa Cancer Res 51 1991 1564 1567
93. T.P. Pretlow T.A. Brasitus N.C. Fulton K-ras mutations in putative preneoplastic lesions in human colon J Natl Cancer Inst 85 1993 2004 2007
94. 2 Gut 35 1994 675 678
95. Y. Remvikos O. Tominaga P. Hammel Increased p53 protein content of colorectal tumours correlates with poor survival Br J Cancer 66 1992 758 764
96. B. Rigas I.S. Goldman L. Levine Increased eicosanoid levels in human colon cancer J Lab Clin Med 122 1993 518 523
97. H. Rivera P. Simi S. Rossi A constitutional 5q23 deletion J Med Genet 27 1990 267 268
98. C. Rodriguez G. Monges P. Rouanet CD44 expression patterns in breast and colon tumors: A PCR-based study of splice variants Int J Cancer 64 1995 347 354
99. L. Roncucci M. Pedroni R. Fante Cell kinetic evaluation of human colonic aberrant crypts Cancer Res 53 1993 3726 3729
100. L. Roncucci D. Stamp A. Medline Identification and quantification of aberrant crypt foci and microadenomas in the human colon Hum Pathol 22 1991 287 294
101. J.A. Royds R.M. Sharrad B. Wagner Cellular localization of c-myc product in human colorectal epithelial neoplasia J Pathol 166 1992 225 233
102. B. Rubinfeld B. Souza I. Albert Association of the APC gene product with β-catenin Science 262 1993 1731 1734
103. H. Sano Y. Kawahito R.L. Wilder Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res 1995 55
104. P. Shaw R. Bovey S. Tardy Induction of apoptosis by wild-type p53 in a human colon tumor–derived cell line Proc Natl Acad Sci USA 89 1992 4495 4499
105. D. Shibata M.A. Reale P. Lavin The DCC protein and prognosis in colorectal cancer N Engl J Med 335 1996 1727 1732
106. D. Sidransky T. Tokino S.R. Hamilton Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors Science 256 1992 102 105
107. K. Sikora S. Chan G. Evan c-myc oncogene expression in colorectal cancer Cancer 59 1987 1289 1295
108. A.J. Smith H.S. Stern M. Penner Somatic APC and K-ras mutations in aberrant crypt foci from human colons Cancer Res 54 1994 5527 5530
109. D.R. Smith T. Myint Goh H.-S. Over-expression of the c-myc proto-oncogene in colorectal carcinoma Br J Cancer 68 1993 407 413
110. E. Solomon R. Voss V. Hall Chromosome 5 allele loss in human colorectal carcinomas Nature 328 1987 616 619
111. L. Spirio S. Olschwang J. Groden Alleles of the APC gene: An attenuated form of familial polyposis Cell 75 1993 951 957
112. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility J Clin Oncol 14 1996 1730 1736
113. L.-K. Su K.W. Kinzler B. Vogelstein Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene Science 256 1992 668 670
114. L.-K. Su B. Vogelstein K.W. Kinzler Association of the APC tumor suppressor proteins with catenins Science 262 1993 1734 1737
115. Y. Takagi H. Kohmura M. Futamura Somatic alterations of the DPC4 gene in human colorectal cancers in vivo Gastroenterology 111 1996 1369 1372
116. c-src in progressive stages of colorectal cancer J Clin Invest 91 1993 53 60
117. M. Tsujii R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxidase synthase 2 Cell 83 1995 493 501
118. V.E. Velculescu W.S. El-Deiry Biological and clinical importance of the p53 tumor suppressor gene Clinical Chemistry 42 1996 858 868
119. B. Vogelstein E.R. Fearon S.R. Hamilton Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
120. 1 arrest in human cancer cells Cancer Res 55 1995 5187 5190
121. c-src activity in well and poorly differentiated human colon carcinomas and cell lines J Clin Invest 90 1992 815 821
122. S.J. Winawer A.G. Zauber M.N. Ho Prevention of colorectal cancer by colonoscopic polypectomy N Engl J Med 329 1993 1977 1981
123. A. Yamaguchi T. Urano T. Goi Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients J Clin Oncol 14 1996 1122 1127
124. K. Yoshida T. Sugino J. Bolodeoku Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene J Clin Pathol 49 1996 300 305